APREPITANT AMELIORATES CYCLOPHOSPHAMIDE-INDUCED TESTICULAR TOXICITY IN MICE VIA SUPPRESSION OF P38 MITOGEN-ACTIVATED PROTEIN KINASE
Mansoura Medical Journal · 01.01.2025 · 54 (4)
DOI: 10.58775/2735-3990.1460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mansoura Medical Journal, online erschienen am 01.01.2025. Verfasst von Suzan Awad AbdelGhany Morsy und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
While cyclophosphamide (CP) is a commonly used immunosuppressant and anticancer drug, it has a high risk of testicular toxicity. The current study evaluated the protective and therapeutic actions of aprepitant (APR), a neurokinin-1 receptor blocker, against CP-induced testicular toxicity in mice and the role of oxidative stress and phosphorylated P38 mitogen-activated protein kinase (p-P38 MAPK) in this action.
Methods
Forty male mice were assigned to four groups: control (vehicle only), CP-induced testicular toxicity (single 200 mg/kg intraperitoneal CP dose), APRprotected (20 mg/kg/day APR starting one day before CP, continued for 30 days), and APR-treated (same APR dose starting one hour after CP). Animals were sacrificed; testes were excised for sperm evaluation, histological examination of haematoxylin and eosin-stained sections, and biochemical analysis of malondialdehyde, reduced glutathione, and p-P38 MAPK levels.
Results
APR improved sperm count, increased the percentage of active sperm, decreased dead sperm, and conserved testicular tissue architecture, according to histological analysis, in comparison to the CP-induced testicular toxicity-untreated group. It also raised the level of reduced glutathione while reducing malondialdehyde levels and p-P38 MAPK expression. Compared to the treated group, these improvements were more pronounced in the APR-preventive group.
Conclusion
APR ameliorated the CP-induced testicular toxicity in mice by suppressing p-P38 MAPK and oxidative stress, preserving testicular tissue and spermatogenesis. Protective use of APR produced a more pronounced improvement
Zitieren
APA
Morsy, S. A. A., Eltrawy, A. H., Khalil, N. A., MM, A. E., Saeed, N. M. M., & Khamis, G. M. (2025). APREPITANT AMELIORATES CYCLOPHOSPHAMIDE-INDUCED TESTICULAR TOXICITY IN MICE VIA SUPPRESSION OF P38 MITOGEN-ACTIVATED PROTEIN KINASE. Mansoura Medical Journal, 54(4). https://doi.org/10.58775/2735-3990.1460
Vancouver
Morsy SAA, Eltrawy AH, Khalil NA, MM AE, Saeed NMM, Khamis GM. APREPITANT AMELIORATES CYCLOPHOSPHAMIDE-INDUCED TESTICULAR TOXICITY IN MICE VIA SUPPRESSION OF P38 MITOGEN-ACTIVATED PROTEIN KINASE. Mansoura Medical Journal. 2025;54(4). doi:10.58775/2735-3990.1460
BibTeX
@article{Morsy2025,
author = {Morsy, Suzan Awad AbdelGhany and Eltrawy, Amira H. and Khalil, Nehal Adel and MM, Abd ElAziz and Saeed, Nourhan Mohamed Mohamed and Khamis, Gehad M.},
title = {APREPITANT AMELIORATES CYCLOPHOSPHAMIDE-INDUCED TESTICULAR TOXICITY IN MICE VIA SUPPRESSION OF P38 MITOGEN-ACTIVATED PROTEIN KINASE},
journal = {Mansoura Medical Journal},
year = {2025},
volume = {54},
number = {4},
doi = {10.58775/2735-3990.1460}
}
EUVIMED